Phil Huber

Director-Operations & Finance at Sequana Medical AG

Phil Huber

Phil Huber

Director-Operations & Finance at Sequana Medical AG

Biography

Phil Huber holds the position of Director-Operations & Finance at Sequana Medical AG. Mr. Huber previously was Chief Operating Officer & Chief Financial Officer at ILIAS-medical GmbH. Mr. Huber received a graduate degree from the University of Zurich.

Overview
Career Highlights

ILIAS-medical GmbH

RelSci Relationships

32

Number of Boards

1

Relationships
RelSci Relationships are individuals Phil Huber likely has professional access to. A relationship does not necessarily indicate a personal connection.

Managing Partner, Healthcare at VI Partners AG

Relationship likelihood: Average

Member-Supervisory Board at Cardiola AG

Relationship likelihood: Average

Former Chairman at Cardiola AG

Relationship likelihood: Average

Chief Executive Officer & Executive Director at Sequana Medical NV

Relationship likelihood: Average

Chief Financial Officer at Sequana Medical NV

Relationship likelihood: Average

Chief Commercial Officer at Sequana Medical AG

Relationship likelihood: Average

Chief Commercial Officer at Sequana Medical AG

Relationship likelihood: Average

Consulting Chief Medical Officer at Sequana Medical AG

Relationship likelihood: Average

Chief Medical Officer at Sequana Medical AG

Relationship likelihood: Average

Former Founder, President & Chief Executive Officer at Sequana Medical AG

Relationship likelihood: Average

Paths to Phil Huber
Potential Connections via
Relationship Science
You
Phil Huber
Director-Operations & Finance at Sequana Medical AG
Education

ETH Zurich is an engineering, science, technology, mathematics, and management university. It is an integral part of the Swiss Federal Institutes of Technology Domain (ETH Domain) that is directly subordinate to Switzerland's Federal Department of Economic Affairs, Education, and Research. ETH Zurich is consistently rated among the top universities in the world. It is considered the best university in continental Europe by the Shanghai Ranking ARWU, the Times Higher Education World University Rankings, and the QS World University Ranking. It is currently ranked 4th in Europe overall, and 8th best university in the world in engineering, science, and technology. Twenty-one Nobel Prizes have been awarded to students and professors of the institute in the past. The most famous of them is Albert Einstein in 1921 and the most recent is Richard F. Heck in 2010. It is a founding member of the IDEA League and the International Alliance of Research Universities (IARU); and a member of the CESAER network. ETH Zurich was founded by the Swiss Federal Government in 1854 with the stated mission to educate engineers and scientists, serve as a national center of excellence in science and technology, and provide a hub for interaction between the scientific community and industry.

MA Business Administration

University of Zurich is a higher education institute that offers a wide variety of Master's, Bachelor's, and Ph.D. programs. The company also specializes in the fields of clinical medicine, immunology, neuroscience, and structural biology as well as in economics. It also brings benefits to both the private and the public sectors. It makes findings from cutting-edge research available to the public in accessible and engaging lecture series and panel discussions. In addition, the University of Zurich providing a dynamic education based on critical thinking and interdisciplinary exposure. The university is committed to being an internationally significant research university, with graduate, undergraduate, and professional programs of excellent quality. University of Zurich was founded on April 29, 1833, and is headquartered in Zurich, Switzerland.

Career History
Director-Operations & Finance
Tenure Unconfirmed

Sequana Medical AG operates as a medical device company. It specializes in the production and design of implantable pump systems to manage fluid balance within the body. The firm offers the Alfapump system, its proprietary solution to manage and remove ascites, which can occur as a symptom of liver disease, cancer, or congestive heart failure and its focus areas encompass clinical research, product innovation, and technology development. The company was founded by Noel L. Johnson in 2000 and is headquartered in Zurich, Switzerland.

Chief Operating Officer & Chief Financial Officer
Prior

ILIAS-medical GmbH develops artificial lungs for the treatment of acute respiratory failure. Its systems can be self sufficient operated by batteries. The firm's products are used for intensive care transport with ambulances or helicopters. The company was founded in December 2007 by Albert Grosser, Ulrike Roos, Hayat Koubaa, Philipp Mayer and Andreas Strauss and is headquartered in Bochum, Germany.

Manager
Prior

UBS AG engages in the provision of financial advisory solutions for private and institutional investors, intermediaries, and wealth management clients. The firm focuses on the areas of wealth and asset management, as well as investment banking. It offers retail investment products, global financing services, investment research, bespoke financing, traditional investments, as well as bonds and equities. The company was founded on June 29, 1998 and is headquartered in Zurich, Switzerland.

Boards & Committees
Member, Sounding Board
Prior

Cardiola AG develops solutions for treating congestive heart failure. It conducts research on treating heart failure. The firm manufactures therapeutic device for heart treatment services. The company was founded by Larryin Lapanashvili in 2000 and it is headquartered in Winterhur, Switzerland.

Other Affiliations

Phil Huber is affiliated with Sequana Medical AG, ILIAS-medical GmbH, UBS AG, Cardiola AG

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Phil Huber. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Phil Huber's profile does not indicate a business or promotional relationship of any kind between RelSci and Phil Huber.